Is CVE-2026-31071 in the CISA KEV catalog?

No. CVE-2026-31071 is not currently on the CISA Known Exploited Vulnerabilities list.

What is the CVSS severity of CVE-2026-31071?

CVE-2026-31071 has a CVSS v3 base score of 9.1 (CRITICAL).

What is the EPSS score for CVE-2026-31071?

CVE-2026-31071 has an EPSS score of 0.55% (41th percentile), estimating the probability of exploitation in the next 30 days.

CVE & CISA-KEV Catalog

CVE-2026-31071

CRITICAL

9.1

CVSS v3

NVD

Description

API endpoints in LalanaChami Pharmacy Management System (commit 5c3d028) lack authentication middleware. Unauthenticated remote attackers can exploit this to dump all user records (including bcrypt password hashes) via /api/user/getUserData, modify drug inventory, and access private medical prescription data via /api/doctorOder.

CWE-306

CVSS v3 Vector

Exploitability

Attack VectorNetwork

Attack ComplexityLow

Privileges RequiredNone

User InteractionNone

ScopeUnchanged

Impact

ConfidentialityHigh

IntegrityHigh

AvailabilityNone

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N

Exploit Intelligence

0.55%probability of exploitation in 30 days

41stpercentile

Moderate risk: more likely to be exploited than 41% of all known CVEs.

References

Find and fix vulnerabilities across your fleet

TridentStack Control continuously scans your Windows, macOS, and Linux fleet for known vulnerabilities, prioritizes them by severity and active exploitation, and patches them automatically.

Start free

This product uses NVD data but is not endorsed or certified by the NVD. EPSS scores courtesy of FIRST.org (https://www.first.org/epss). Source: CISA KEV Catalog. Data as of 2026-05-20.